Vericel (VCEL) Capital Expenditures (2010 - 2026)
Vericel (VCEL) reported Capital Expenditures of $1.3 million for Q1 2026, down 91.16% on a YoY basis from $14.2 million in Q1 2025, and down 95.17% sequentially from $26.0 million in Q4 2025.
Vericel (VCEL) Capital Expenditures (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 16 years of Capital Expenditures data on file, last reported at $1.3 million in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 91.16% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $14.2 million (up 1.51% YoY), and the FY2025 full-year result was $27.2 million, up 128.29% from the prior year.
- Capital Expenditures fell to $1.3 million in Q1 2026, from $26.0 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $26.0 million in Q4 2025 to a low of -$38.3 million in Q4 2024.
- A 5-year average of $3.4 million and a median of $3.1 million in 2022 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 1456.46% in 2024, while the deepest fall reached 935.27% in 2024.
- Tracing VCEL's Capital Expenditures over 5 years: stood at $7.3 million in 2022, then plunged by 37.56% to $4.6 million in 2023, then slumped by 935.27% to -$38.3 million in 2024, then surged by 167.99% to $26.0 million in 2025, then tumbled by 95.17% to $1.3 million in 2026.
- Business Quant data shows VCEL's Capital Expenditures at $1.3 million in Q1 2026, $26.0 million in Q4 2025, and -$21.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn | 1.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.26 Mn |
| Mar 31, 2026 | 1.26 Mn |
| Dec 31, 2025 | 26.03 Mn |
| Dec 31, 2025 | 26.03 Mn |
| Sep 30, 2025 | -21.22 Mn |
| Sep 30, 2025 | -21.22 Mn |
| Jun 30, 2025 | 8.13 Mn |
| Jun 30, 2025 | 8.13 Mn |
| Mar 31, 2025 | 14.21 Mn |
| Mar 31, 2025 | 14.21 Mn |
| Dec 31, 2024 | -38.29 Mn |
| Dec 31, 2024 | -38.29 Mn |
| Sep 30, 2024 | 19.41 Mn |
| Sep 30, 2024 | 19.41 Mn |
| Jun 30, 2024 | 18.66 Mn |
| Jun 30, 2024 | 18.66 Mn |
| Mar 31, 2024 | 12.12 Mn |
| Mar 31, 2024 | 12.12 Mn |
| Dec 31, 2023 | 4.58 Mn |
| Dec 31, 2023 | 4.58 Mn |